How Did Noumi Limited (ASX:NOU) Report AUD 648.4 Million in FY26 Revenue?

Aditi Sarkar

28 October 2026 03:24 PM AEDT

How Did Noumi Limited (ASX:NOU) Report AUD 648.4 Million in FY26 Revenue?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

FY26 revenue rose 8.8% to AUD 648.4 million
Adjusted operating EBITDA increased 7.6% to AUD 61.8 million
Dairy and Nutritionals adjusted EBITDA increased 94.1% to AUD 21.6 million

Noumi Limited (ASX:NOU) shares were quoted at AUD 0.12, with a 0.00% movement. The company operates in the food, dairy and nutrition sector and reported financial results and operational developments for FY26. Its disclosures include figures for the financial year ended 30 June 2026 and, where specified, subsequent operating information. The business update covers its principal activities, financial results and management priorities.

Revenue and Group Earnings

For the financial year ended 30 June 2026, Noumi Limited reported group revenue of AUD 648.4 million, an increase of 8.8% over FY25. Adjusted operating EBITDA rose 7.6% to AUD 61.8 million. The group stated that commodity pricing and the mix of brands, markets and sales channels contributed to revenue growth. Cash generated from trading reached AUD 69.1 million, an increase of 3.2% from the previous financial year. Adjusted operating EBITDA is a management-defined non-IFRS measure and is distinct from statutory earnings.

Plant-Based Milk and Milklab

Plant-Based Milks recorded sales of AUD 186.3 million, up 2.4% year on year, while the segment’s adjusted operating EBITDA was AUD 43.1 million, down 14.2%. The company described an increase in marketing and capability spending during the period. Total Milklab brand revenue, covering both plant and dairy products, rose 5.5%. Milklab export revenue increased 11.2% and retail revenue grew 44.6%, while its hospitality channel was flat. Noumi also reported growth across several other branded products.

Dairy and Nutritionals Performance

Dairy and Nutritionals generated revenue of AUD 462.0 million and adjusted operating EBITDA of AUD 21.6 million, an increase of 94.1%. The company attributed part of the earnings improvement to favourable commodity pricing for bulk cream. It reported that the segment achieved a fourth consecutive year of earnings improvement. Branded revenue changes disclosed by Noumi included Australia’s Own up 12.3%, Uprotein up 18.0% and Vital Strength up 11.6%.

Business Priorities

Noumi described continuing work on brands, safety, quality, operational capability and digital systems. The FY26 results presentation referred to consumer demand for protein and lactose-free products and the company’s investment in Milklab. Future outcomes remain subject to operating conditions and the commercial execution of the plans set out by management.

FAQs

Q: What was Noumi’s FY26 revenue?

A: AUD 648.4 million, up 8.8% from FY25.

Q: How much was adjusted operating EBITDA?

A: AUD 61.8 million, up 7.6%.

Q: How did Plant-Based Milks perform?

A: Sales rose 2.4% to AUD 186.3 million.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.